Filing Details
Roivant Sciences Ltd. (NASDAQ:ROIV) filed a Form 8-K with the Securities and Exchange Commission on October 21, 2026, disclosing a material event.
8k filedNASDAQ:ROIV
Roivant Sciences Ltd. (ROIV) Reports Material Event to SEC
Roivant Sciences Ltd. (NASDAQ:ROIV) filed a Form 8-K with the Securities and Exchange Commission on October 21, 2026, disclosing a material event.
At publication ·
What changed
Roivant Sciences Ltd. (NASDAQ:ROIV) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Roivant Sciences filed a Form 8-K with the SEC on October 21, 2026, disclosing a material event requiring shareholder notification.
- The company's stock trades at $36.80 with a market capitalization of $14.8 billion.
- Material events reported in 8-K filings typically include leadership changes, acquisitions, asset sales, or financial guidance revisions.
Market Context
Roivant Sciences Ltd.'s stock currently trades at $36.80 with a market capitalization of $14.8B. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Roivant Sciences Ltd.'s stock.
All SEC filings for Roivant Sciences Ltd. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ROIV Stock Page
Frequently Asked Questions
Where can I read ROIV's SEC filings?
Browse all filings on our ROIV SEC filings page.
What types of SEC filings does Roivant Sciences Ltd. file?
Public companies like Roivant Sciences Ltd. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.